Riskpilot← Back to searchSign inGet full accessReell Hälsa i Lund AB
ABActiveOrg 5566598594Långgatan 4General medical practice activities · NACE 8621Est. 20040 employees
Revenue 2023
SEK 1,8M
+399% vs 2022
EBITDA margin
42.5%
+222% vs 2022
Equity ratio
61.1%
Financial strength
Net profit 2023
SEK 439K
+140% vs 2022
| Revenue | SEK 1,8M | +399% |
| EBITDA | SEK 751K | +222% |
| Net profit | SEK 439K | +140% |
| Total assets | SEK 1,3M | +74% |
| Equity | SEK 787K | +76% |
| Employees | 0 | — |
Legal name
Reell Hälsa i Lund AB
Org number
5566598594
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 april 2004
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 2 styrelsesuppleanter.
Company purpose
Föremålet för bolagets verksamhet är bedriva förmedling och uthyrning av vårdpersonal och personal i ledarskapsroller. Försäljning av medicinska produkter och tjänster. Organisera och tillhandahålla handledning och professionell utveckling. Företaget skall vidare bedriva aktiehandel och förvärva och förvalta fastigheter och därmed förenlig verksamhet.
Address
Långgatan 4
Email
carl.weitkamper@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 160 | 34 | 614 | 354 | 1 767 |
| Staff expenses | — | — | — | — | −155 |
| EBITDA | 21 | 21 | 457 | 233 | 751 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 21 | 21 | 457 | 233 | 751 |
| Net financials | −1 | 2 | — | −1 | −9 |
| Profit before tax | 20 | 22 | 458 | 232 | 555 |
| Tax | −0 | −0 | −85 | −49 | −116 |
| Net profit | 20 | 22 | 373 | 183 | 439 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 169 | 213 | 636 | 740 | 1 289 |
| Equity | 152 | 175 | 441 | 448 | 787 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 16 | 39 | 196 | 292 | 315 |
| Total debt | 16 | 39 | 196 | 292 | 315 |
EBITDA margin
42.5%
This company
15.8%
Market median
+169% vs market
20192023
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20192023
Return on equity
55.8%
This company
18.4%
Market median
+203% vs market
20192023
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
20192023
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20192023
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CE Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
MP Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Reell Hälsa i Lund AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Peter Peterson | Chief Executive Officer | 0 companies |
| Carl Erik Fabian Weitkämper | Chief Executive Officer | 0 companies |
| Vera Magdalena Weitkämper | Deputy Board Member | 0 companies |
| Viktor Emil John Peterson | Deputy Board Member | 0 companies |
| Najah Nadia Seoud Ekelin | Board of Directors | 0 companies |